AI assistant
Sending…
Vaxcyte, Inc. — Director's Dealing 2021
Oct 7, 2021
31100_dirs_2021-10-06_3acb4825-83d4-444e-832c-5835c7e07855.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-10-01
Reporting Person: Dhaliwal Harpreet S. (SVP Cml Mfg & Supply Chain)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities owned. | 0 | Direct |
More from Vaxcyte, Inc.
Regulatory Filings
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 24